UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
Amendment No. 1
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) July 5, 2017
Cross Country Healthcare, Inc.
(Exact name of registrant as specified in its charter)
| | Delaware | | 0-33169 | | 13-4066229 | |
| | (State or Other Jurisdiction | | (Commission | | (I.R.S. Employer | |
| | of Incorporation) | | File Number) | | Identification No.) | |
5201 Congress Avenue, Suite 100B, Boca Raton, FL 33487
(Address of Principal Executive Office) (Zip Code)
(561) 998-2232
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Introductory Note
This Amendment 1 is being filed to furnish financial statements and pro forma financial information as required by Article 3-05 and Article 11 of Regulation S-X in connection with the transaction described in Item 2 of this Current Report on Form 8-K, originally filed on July 6, 2017.
Item 9.01 Financial Statements and Exhibits.
(a) Financial statements of businesses acquired.
The unaudited condensed consolidated balance sheet of Advantage RN, LLC and subsidiaries as of June 30, 2017, and the related condensed consolidated statements of operations and cash flows for the six months ended June 30, 2017 and the six months ended June 30, 2016, and the notes to the condensed consolidated financial statements are filed as Exhibit 99.1 to this Amendment and are incorporated herein by reference.
The audited consolidated balance sheets of Advantage RN, LLC and subsidiaries as of December 31, 2016 and December 31, 2015 and the related consolidated statements of operations, changes in members' equity and cash flows for the years ended December 31, 2016 and December 31, 2015, and the notes to the consolidated financial statements are filed as Exhibit 99.2 to this Amendment and are incorporated herein by reference.
The audited consolidated balance sheets of Advantage RN, LLC and subsidiaries as of December 31, 2015 and December 31, 2014 and the related consolidated statements of operations, changes in members' equity and cash flows for the years ended December 31, 2015 and December 31, 2014, and the notes to the consolidated financial statements are filed as Exhibit 99.3 to this Amendment and are incorporated herein by reference.
(b) Pro forma financial information.
The unaudited pro forma condensed combined statements of operations for the six months ended June 30, 2017 and for the year ended December 31, 2016, and the notes to the unaudited pro forma condensed combined financial statements are filed as Exhibit 99.4 to this Amendment and are incorporated herein by reference.
(d) Exhibits
Exhibit | | Description |
| | Consent of Hammerman, Graf, Hughes & Company, Inc., Independent Auditors |
| | Unaudited condensed consolidated balance sheet of Advantage RN, LLC and subsidiaries as of June 30, 2017, and the related condensed consolidated statements of operations and cash flows for the six months ended June 30, 2017 and the six months ended June 30, 2016, and the notes to the condensed consolidated financial statements |
| | Audited consolidated balance sheets of Advantage RN, LLC and subsidiaries as of December 31, 2016 and December 31, 2015 and the related consolidated statements of operations, changes in members' equity and cash flows for the years ended December 31, 2016 and December 31, 2015, and the notes to the consolidated financial statements |
| | Audited consolidated balance sheets of Advantage RN, LLC and subsidiaries as of December 31, 2015 and December 31, 2014 and the related consolidated statements of operations, changes in members' equity and cash flows for the years ended December 31, 2015 and December 31, 2014, and the notes to the consolidated financial statements |
| | The unaudited pro forma condensed combined statements of operations for the six months ended June 30, 2017 and for the year ended December 31, 2016, and the notes to the unaudited pro forma condensed combined financial statements |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| | CROSS COUNTRY HEALTHCARE, INC. |
| | | |
| Date: September 15, 2017 | By: | /s/ William J. Burns |
| | Name: William J. Burns |
| | | Title: Chief Financial Officer |
| | | |
